-
News | 2021.03.03
Primary Immunodeficiencies: launch of the second phase of the ATun-DIP's project in the North-Western regions of Tunisia
After more than three years of activities in the underprivileged regions of the Centre and South of Tunisia, the second phase of the ATun-DIP's project (Improvement of the management of Tunisian children suffering from Primary Immunodeficiency Diseases) started on February the 4th, 2021. The project, coordinated by the Institut Pasteur de Tunis in collaboration with several partners including the...
-
Document de presse | 2021.04.23
Professor Stewart Cole appointed Institut Pasteur President for a further two-year term
On Friday April 16, the Institut Pasteur Board of Governors appointed Professor Stewart Cole President for a further two-year term from January 1, 2022 to December 31, 2023.This decision is based on the President's commitment to the development and implementation of the 2019-2023 Strategic Plan, which includes the key priority of tackling infectious diseases, and on his ability to carry out the...
-
Document de presse | 2021.10.11
SARS-CoV-2 Alpha, Beta and Delta variants display enhanced viral fusion properties compared to ancestral strains
In a new study published in EMBO Journal on October 2, 2021, scientists from the Institut Pasteur, the CNRS, Université de Paris, the Vaccine Research Institute and Sorbonne University examined the fusion mechanisms of different SARS-CoV-2 variants: Alpha (initially identified in the United Kingdom), Beta (initially identified in South Africa) and Delta (initially identified in India). The Delta...
-
News | 2023.11.15
The Institut Pasteur pays tribute to Dr. Grancher, physician and “Pasteurian”
On November 7, 2023, the Grancher Foundation celebrated its 120th anniversary on the Institut Pasteur campus. The Foundation was established by Dr. Joseph Grancher. It was an opportunity for the Institut Pasteur's President to pay tribute to the physician best known for his work on tuberculosis – a disease that the Institut Pasteur continues to fight.
-
Portrait | 2022.03.29
Jean-Claude Manuguerra: viruses, animals and humans
It all started with a veterinarian and a cross-eyed lionJean-Claude Manuguerra was 7 when he decided that he wanted to become a veterinarian, to "save animals" – like in the TV series Daktari, which he was an avid fan of at the time. In the series, Dr. Marsh Tracy was a vet who cared for local animals and ran the Wameru Study Center for Animal Behavior in Kenya. Marsh Tracy was aided in his day-...
-
News | 2022.10.05
A series of events to mark the bicentenary of Louis Pasteur’s birth
The Institut Pasteur is continuing to celebrate the bicentenary of Louis Pasteur's birth by organizing a major conference in December and also by partnering with events organized by other institutions and participating in official 2022 bicentenary festivals and conferences. Check out the calendar of events below and at www.pasteur2022.fr.
-
Document de presse | 2021.03.09
ComCor: Study examining the sociodemographic, behavioral and practical factors associated with SARS-CoV-2 infection
The ComCor study is conducted by the Institut Pasteur in partnership with the French National Health Insurance Fund (CNAM), Ipsos and Santé publique France.Intermediate analysis, on March 1, 2021The ComCor study, which currently covers the period from October 1, 2020 to January 31, 2021, includes 77,208 participants with acute SARS-CoV-2 infection, excluding healthcare workers (8.2% of those...
-
Document de presse | 2021.03.23
SARS-CoV-2 variants of interest can infect mice: host range extended
SARS-CoV-2, the virus responsible for COVID-19, is capable of infecting some species, while others are naturally resistant to it. This determines the "host range" of the virus. The SARS-CoV-2 host range includes humans, non-human primates, hamsters, mink and cats. Since the start of the pandemic, mice and rats had proven to be resistant to SARS-CoV-2, because their ACE2 receptor, which allows the...
-
News | 2023.05.23
Creation of an European Biocluster for Emerging Infectious Diseases
The project "Biocluster Français pour l’Innovation en Infectiologie" (BCF2I) has been selected for the Healthcare Innovation 2030 plan. This strategy aims to strengthen biomedical research in France. Coordinated by Lyonbiopôle and supported by the Auvergne-Rhône-Alpes region, this European-scale cluster aims to accelerate progress in the field of emerging diseases, by working with the Institut...
-
News | 2023.12.11
Toscana virus causes unexplained encephalitis
A team from the Institut Pasteur in Paris, in collaboration with researchers in Spain, has identified Toscana virus in samples taken from patients in southern Spain. This virus is responsible for cases of encephalitis that have never been fully explained. The presence of this virus in the samples challenges the assumption that it was rare in the Mediterranean region. Thanks to this discovery,...
